RNU1-153P

Across TCGA pan-cancer cohorts, RNU1-153P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RNU1-153P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU1-153P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-153P expression acts as an unfavorable survival marker, although some lineages such as PAAD and BLCA show a favorable association.

UVM, PAAD, and LUAD are the cancer types where RNU1-153P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.423	0.737	<.001	115	view →
PAAD	OS	Median	II,III,IV	0.509	0.247	<.001	45	view →
LUAD	DFS	Median	All	0.743	0.871	<.001	43	view →
KIRC	OS	Quartile	All	0.534	0.719	.001	26	view →
BLCA	OS	Median	II,III,IV	0.769	0.665	.014	26	view →
SKCM	OS	Tertile	III,IV	0.563	0.242	.002	25	view →
CESC	DFS	Tertile	All	0.646	0.824	.001	24	view →
LGG	DFS	Tertile	All	0.773	0.888	<.001	21	view →
ACC	DFS	Quartile	All	0.454	0.805	.002	18	view →
PRAD	DFS	Tertile	All	0.697	0.836	.003	16	view →
KICH	DFS	Quartile	III,IV	0.228	0.912	.008	10	view →
COAD	OS	Median	II,III,IV	0.846	0.686	.013	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RNU1-153P–UVM (OS)

Open the UVM breakdown →